These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38179337)

  • 21. What Generates Attention to Health in Trade Policy-Making? Lessons From Success in Tobacco Control and Access to Medicines: A Qualitative Study of Australia and the (Comprehensive and Progressive) Trans-Pacific Partnership.
    Townsend B; Friel S; Schram A; Baum F; Labonté R
    Int J Health Policy Manag; 2021 Oct; 10(10):613-624. PubMed ID: 32610761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do actors with asymmetrical power assert authority in policy agenda-setting? A study of authority claims by health actors in trade policy.
    Townsend B; Schram A; Labonté R; Baum F; Friel S
    Soc Sci Med; 2019 Sep; 236():112430. PubMed ID: 31351362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018.
    Wouters OJ
    JAMA Intern Med; 2020 May; 180(5):688-697. PubMed ID: 32125357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010-2021.
    Rotering T; Apollonio DE
    Int J Drug Policy; 2022 Apr; 102():103585. PubMed ID: 35085854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commercial lobbying and political contributions: an Australian scoping review.
    Lacy-Nichols J; Johnson M; Cullerton K
    Aust N Z J Public Health; 2023 Aug; 47(4):100073. PubMed ID: 37478519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging.
    Curran L; Eckhardt J
    Rev Int Polit Econ; 2017; 24(1):87-118. PubMed ID: 28630533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lobbying by omission: what is known and unknown about harmful industry lobbyists in Australia.
    Lacy-Nichols J; Christie S; Cullerton K
    Health Promot Int; 2023 Oct; 38(5):. PubMed ID: 37864804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exposé of the realpolitik of trade negotiations: implications for population nutrition.
    Friel S; Baker P; Thow AM; Gleeson D; Townsend B; Schram A
    Public Health Nutr; 2019 Nov; 22(16):3083-3091. PubMed ID: 31439059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcoholic beverages in trade agreements: Industry lobbying and the public health interest.
    Room R; Gleeson D; Miller M
    Drug Alcohol Rev; 2021 Jan; 40(1):19-21. PubMed ID: 33184904
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of Alcohol Control Policy in Vietnam: Transnational Corporate Interests at the Policy Table, Global Public Health Largely Absent.
    Casswell S
    Int J Health Policy Manag; 2022 Dec; 11(12):3032-3039. PubMed ID: 35942958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthcare lobbying on upstream social determinants of health in the US.
    Counts NZ; Taylor LA; Willison CE; Galea S
    Prev Med; 2021 Dec; 153():106751. PubMed ID: 34343593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taking IT to the Hill. Trade groups send troops to Washington to serve in educational, promotional roles as IT becomes a high-profile legislative issue.
    Morrissey J
    Mod Healthc; 2004 Jun; 34(26):56, 58. PubMed ID: 15242113
    [No Abstract]   [Full Text] [Related]  

  • 34. A proposal for systematic monitoring of the commercial determinants of health: a pilot study assessing the feasibility of monitoring lobbying and political donations in Australia.
    Lacy-Nichols J; Cullerton K
    Global Health; 2023 Jan; 19(1):2. PubMed ID: 36611039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada's Healthy Eating Strategy.
    Gaucher-Holm A; Mulligan C; L'Abbé MR; Potvin Kent M; Vanderlee L
    Global Health; 2022 May; 18(1):54. PubMed ID: 35619107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Well-healed: inside lobbying for health care reform, Part III.
    Int J Health Serv; 1996; 26(1):19-46. PubMed ID: 8932600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Multiplex Network of EU Lobby Organizations.
    Zeng A; Battiston S
    PLoS One; 2016; 11(10):e0158062. PubMed ID: 27792734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Making Inference across Mobilisation and Influence Research: Comparing Top-Down and Bottom-Up Mapping of Interest Systems.
    Berkhout J; Beyers J; Braun C; Hanegraaff M; Lowery D
    Polit Stud (Oxf); 2018 Feb; 66(1):43-62. PubMed ID: 30369638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corporate political activity of the dairy industry in France: an analysis of publicly available information.
    Mialon M; Mialon J
    Public Health Nutr; 2017 Sep; 20(13):2432-2439. PubMed ID: 28689497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conflict of interest and alcohol discourse-a new face but familiar messages.
    Casswell S
    N Z Med J; 2018 Oct; 131(1483):59-62. PubMed ID: 30286066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.